Association of nailfold video- capillaroscopy change with microvascular complications in patients with Type 2 Diabetes mellitus – A cross
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2026
Project Lead
Dr. Sonali Appaiah
Authors
Dr. Sonali Appaiah
Project Status
ongoing
Project Type
ESI